Since establishing operations in the UAE in 1972, Novo Nordisk has forged enduring partnerships, aligning with the country’s vision for advanced healthcare.

Novo Nordisk has invested nearly 12 million AED in research and development over the past decade, impacting more than 90,000 patients through access to cutting-edge therapies and educational platforms.

Our commitment to defeating serious chronic diseases has shaped their journey and purpose for over a century.